Cite

    Alves Rico, S. et al. (2017). Diruthenium(ii, iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer–lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale. 9 (30), pp. 10701-10714. [Online].